Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Balancing intellectual monopoly privileges and the need for essential medicines | Globalization and Health Editorial BioMed Central Open Access Balancing intellectual monopoly privileges and the need for essential medicines Greg Martin 1 Corinna Sorenson2 and Thomas Faunce3 Address 1Science and Research Department World Cancer Research Fund 19 Harley Street London W1G 9QJ UK 2London School of Economics LSE Health Cowdray House Houghton Street London WC2A 2AE UK and 3College of Law Medical School Globalization and Health Project - Centre for Governance of Knowledge and Development Australian National University Australia Email Greg Martin - Corinna Sorenson - Thomas Faunce - Fauncet@ Corresponding author Published 12 June 2007 Received 30 May 2007 Globalization and Health 2007 3 4 doi l744-8603-3-4 Accepted 12 June 2007 This article is available from http content 3 1 4 2007 Martin et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract This issue of Globalization and Health presents a paper by Kerry and Lee that considers the TRIPS agreement and the recent policy debate regarding the protection of public health interest particularly as they pertain to the Doha Declaration. In this editorial we consider the debate the conclusions thereof and identify five questions that should be considered by key stakeholders in ongoing discussions. Background The World Trade Organisation s WTO s agreement on Trade-Related Aspects of Intellectual Property Rights TRIPS has remained controversial ever since its inception at the behest of some of the world s largest multinational corporations. Balancing the need to protect the intellectual property rights IPRs which the third author considers are more accurately described as .
